Publication | Open Access
Preclinical Characterization of Mitochondria-Targeted Small Molecule Hsp90 Inhibitors, Gamitrinibs, in Advanced Prostate Cancer
102
Citations
29
References
2010
Year
Gamitrinibs have preclinical activity and favorable safety in models of drug-resistant and bone metastatic prostate cancer in vivo.
| Year | Citations | |
|---|---|---|
Page 1
Page 1